Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report

Semin Arthritis Rheum. 2018 Oct;48(2):e17-e20. doi: 10.1016/j.semarthrit.2017.12.013. Epub 2018 Jan 6.

Authors

Marco Filetti¹, Elisabetta Anselmi², Serena Macrini², Francesco Rizzo², Daniela Iacono³, Raffaele Giusti², Paolo Marchetti²

Affiliations

¹ Medical Oncology Unit, Sant'Andrea Hospital of Rome, Via di Grottarossa 1035-39, Rome 00189, Italy. Electronic address: [email protected].
² Medical Oncology Unit, Sant'Andrea Hospital of Rome, Via di Grottarossa 1035-39, Rome 00189, Italy.
³ Pulmonary Oncology Unit, San Camillo Forlanini Hospital of Rome Italy.

PMID: 29402438
DOI: 10.1016/j.semarthrit.2017.12.013

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / complications
Adenocarcinoma / drug therapy*
Antineoplastic Agents, Immunological / therapeutic use*
Edema / complications
Edema / drug therapy*
Female
Humans
Lung Neoplasms / complications
Lung Neoplasms / drug therapy*
Middle Aged
Nivolumab / therapeutic use*
Synovitis / complications
Synovitis / drug therapy*
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Nivolumab